KDM1A and cancer: In both CD133− and CD133+ cells, usage of anti-cancer drugs, either oxaliplatin or 5-FU, did not change the LSD1 protein content, indicating the commonly used drugs are not targeting LSD1 for chemotherapy (Figure 2C).